Antiplatelet Therapy in Acute Coronary Syndrome(ACS). Safety and Efficacy of Switching Antiplatelet
NCT02500290 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2019-06-19
Summary
This study aims to describe antiplatelet therapy in ACS in Andalusia and make an assessment of efficacy and safety of hospital use Prasugrel / ticagrelor vs. Clopidogrel and Prasugrel switching to / ticagrelor patients pretreated with clopidogrel.
Conditions
- Acute Coronary Syndrome
Sponsors & Collaborators
-
Fundación Pública Andaluza Progreso y Salud
lead OTHER
Principal Investigators
-
Manuel Almedro Delia, MD · Hospital Universitario Virgen Macarena
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-30
- Primary Completion
- 2019-02-21
- Completion
- 2021-03-31
Countries
- Spain
Study Locations
More Related Trials
-
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT02319941 ·Status: COMPLETED ·Phase: PHASE2
-
Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis
NCT02215993 ·Status: COMPLETED ·Phase: PHASE4
-
Peripheral Endothelial Function Assessment of Patients on Ticagrelor vs. Clopidogrel Who Have Undergone PCI
NCT02469740 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment
NCT02580149 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
NCT02459288 ·Status: UNKNOWN ·Phase: PHASE4
-
Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention
NCT01360437 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
NCT02506140 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Platelet Function Assessment for Atherothrombotic Patients
NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4
-
Clopidogrel And Ticagrelor in Healthy Subjects
NCT02086903 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel
NCT02513004 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Renal Function on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients
NCT02323971 ·Status: UNKNOWN
-
Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
NCT02317198 ·Status: COMPLETED ·Phase: PHASE4
-
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
NCT01869309 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparing Ticagrelor Versus Clopidogrel on Microcirculation
NCT02618733 ·Status: COMPLETED ·Phase: NA
-
The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
NCT02484924 ·Status: COMPLETED
-
A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
NCT00391872 ·Status: COMPLETED ·Phase: PHASE3
-
Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)
NCT01463150 ·Status: COMPLETED ·Phase: PHASE4
-
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
NCT06691191 ·Status: RECRUITING ·Phase: PHASE4
-
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
NCT02925923 ·Status: COMPLETED ·Phase: PHASE2
-
Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS
NCT02048228 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
NCT01641510 ·Status: COMPLETED ·Phase: PHASE3
-
the Effect Between Platelet Reactivation and Antiplatelet Drugs
NCT02198053 ·Status: UNKNOWN
-
Efficacy and Safety Study of Ticagrelor
NCT01812330 ·Status: UNKNOWN ·Phase: PHASE3
-
ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNts
NCT02519608 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Of Efficacy and Safety Between Ticagrelor and Clopidogrel In Chinese
NCT03239067 ·Status: COMPLETED